2. Tall man letters aren't meant to replace drug name safety testing, which is aimed at preventing drugs with similar names from coming onto the market. Set expectations for your organization's performance that are reasonable, achievable and survey-able. Your Name: (optional)
REVISION LOG VERSION DATE AUTHOR CHANGES 0.1 November 2013 Med-ER Workgroup Initial Draft 1.0 April 2014 Med-ER Workgroup Final draft approved by committee Drive performance improvement using our new business intelligence tools.Discover how different strategies, tools, methods, and training programs can improve business processes.Stay up to date with all the latest Joint Commission news, blog posts, webinars, and communications.Learn about Pain Assessment and Management standards for hospitals from the Requirement, Rationale, and References report.Learn more about us and the types of organizations and programs we accredit and certify.Information on all things ambulatory from The Joint CommissionHigh-alert and hazardous medications bear a heightened risk or cause significant patient harm and/or sentinel events when they are used in error and, as a result, require special safeguards.Look-alike/sound-alike (LASA) medications are those, either written or spoken, which may lead to potentially harmful errors when confused with each other.In my work as a Joint Commission ambulatory care surveyor, I see so much confusion in a variety of ambulatory settings about “High-Alert/Hazardous” and “Look-Alike, Sound-Alike” medications (LASA) and how to comply with these critical expectations. Your Name: (optional)
ScienceDirect ® is a registered trademark of Elsevier B.V.Tallman lettering as a strategy for differentiation in look-alike, sound-alike drug names: The role of familiarity in differentiating drug doppelgangersCopyright © 2015 Elsevier Ltd and The Ergonomics Society.
ACCREDITATION. Learn more about why your organization should achieve Joint Commission Accreditation. New More than 8,100 clinical updates —New dosages and indications, Black Box warnings, adverse reactions, nursing considerations, clinical alerts, and patient teaching information New ISMP-recommended tall-man lettering for look alike–sound alike drugs Special focus on U. doi: 10.1097/01.NURSE.0000345220.54439.59
Allows for a quick transfer of a drug from the pharmacy to a nursing unit. Your Email:
Stage 4: User-testing the National Tall Man Lettering List Ensuring the proposed National Tall Man Lettering List was not detrimental was critical to its acceptance. HIPAA is a federal law that protects a patient's private information when it is. Tall Man Lettering uses a combination of lower and upper case letters to highlight the differences between look-alike medicine names, helping to make them more easily distinguishable. See what certifications are available for your health care setting.Find out about the 2020 National Patient Safety Goals® (NPSGs) for specific programs.We help you measure, assess and improve your performance.Learn about the development and implementation of standardized performance measures. Spoken written and electronically transferred. The item(s) has been successfully added to "
Enter the terms you wish to search for. All rights reserved. View them by specific areas by clicking here.Gain an understanding of the development of electronic clinical quality measures to improve quality of care. Medications that should not be crushed because of their special pharmaceutical formulations or characteristics. National Tall Man Lettering List – November 2017 3 Governance The Commission has established an expert advisory panel consisting of frontline clinicians and a pharmacy and medication safety academic to advise the Commission on matters related to Tall Man lettering.